Digital Mammography and Breast Tomosynthesis Ten years ago, most mammography units in the United States were using film screen technology. After the results of the Digital Mammographic Imaging Screening Trial (DMIST), proving digital
Search Results
Update on Emerging Technologies in Breast Imaging
Stephanie K. Patterson and Mitra Noroozian
Strategies for Colon Cancer Screening With Considerations of Cost and Access to Care
Randall W. Burt
Screening for colon cancer in the general population 50 years of age and older, as outlined in the NCCN Clinical Practice Guidelines in Oncology in this volume, has been shown to substantially decrease mortality from this malignancy. 1 – 3
NCCN Guidelines® Insights: Breast Cancer Screening and Diagnosis, Version 1.2023
Featured Updates to the NCCN Guidelines
Therese B. Bevers, Bethany L. Niell, Jennifer L. Baker, Debbie L. Bennett, Ermelinda Bonaccio, Melissa S. Camp, Sona Chikarmane, Emily F. Conant, Mohammad Eghtedari, Meghan R. Flanagan, Jeffrey Hawley, Mark Helvie, Linda Hodgkiss, Tamarya L. Hoyt, Jennifer Ivanovich, Maxine S. Jochelson, Swati Kulkarni, Rachael B. Lancaster, Caitlin Mauer, Jessica Maxwell, Bhavika K. Patel, Mark Pearlman, Liane Philpotts, Donna Plecha, Jennifer K. Plichta, Shadi Shakeri, Mary Lou Smith, Clarie L. Streibert, Roberta M. Strigel, Lusine Tumyan, Nicole S. Winkler, Dulcy E. Wolverton, Mary Anne Bergman, Rashmi Kumar, and Katie Stehman
10, 2023; Expiration date: September 10, 2024 Learning Objectives: Upon completion of this activity, participants will be able to: • Integrate into professional practice the updates to the NCCN Guidelines for Breast Cancer Screening and
Refining the Patient Navigation Role in a Colorectal Cancer Screening Program: Results From an Intervention Study
Elizabeth A. Rohan, Beth Slotman, Amy DeGroff, Kerry Grace Morrissey, Jennifer Murillo, and Paul Schroy
colonoscopy screening in a medically disadvantaged population Ascertain PN intervention activities during colonoscopy screening most valued by patients that potentially improve patient outcomes Background Oncology patient navigation (PN) is
The Changing Face of Cervical Cancer Screening in the United States
Warner K. Huh
With the introduction of widespread Pap smear screening starting in the 1940s, the United States has seen at least a 50% reduction in the incidence and mortality of invasive cervical cancer. In light of the ease of sampling, the long pre
Does Colonoscopy Work?
David G. Hewett, Charles J. Kahi, and Douglas K. Rex
://www.medscape.com/cme/jnccn ; (4) view/print certificate. Learning Objectives Upon completion of this activity, participants will be able to: • Specify the effectiveness of other screening modalities in the prevention of colorectal cancer • Describe outcomes of research
Increasing Colorectal Screening Uptake in Spouses of Patients With Colorectal Cancer Using a Randomized Behavioral Trial
Jerrald Lau, Lina Choe, Daphne Hui Juan Lee, Athena Ming-Gui Khoo, Wei-Ling Koh, Cherie Peh, Alyssa Ng, Tian-Zhi Lim, Bettina Lieske, Kuok-Chung Lee, Choon-Seng Chong, Choon-Sheong Seow, Christopher H.L. Keh, Jing-Yu Ng, and Ker-Kan Tan
Background Colorectal cancer (CRC) remains one of the most prevalent cancers worldwide and is one of the few cancers for which screening has been associated with better survival and morbidity outcomes. 1 Much effort has been rightly put into
PSA Testing Use and Prostate Cancer Diagnostic Stage After the 2012 U.S. Preventive Services Task Force Guideline Changes
Christopher J. Magnani, Kevin Li, Tina Seto, Kathryn M. McDonald, Douglas W. Blayney, James D. Brooks, and Tina Hernandez-Boussard
screening and treatment, partly because of the difficulty in distinguishing aggressive from indolent cancers. 2 Most prostate cancers are asymptomatic, are detected by primary care–directed screening, are slow-growing, and will not become clinically evident
Cervical Cancer Screening
Stanford Comprehensive Cancer Center
Cervical carcinoma remains a health issue for women worldwide. Cervical cytology screening is the current method for early detection, and the NCCN Cervical Cancer Screening Clinical Practice Guidelines in Oncology provide direction for evaluating and managing this process, including clarified and revised recommendations on screening techniques and intervals and follow-up of abnormal screening results, including colposcopy. Human papillomavirus (HPV) DNA testing for primary cervical cancer has been approved by the FDA, and HPV DNA testing for high-risk virus types can also be used as a component of both primary screening and workup of abnormal cytology results. Colposcopy, along with colposcopically directed biopsies, has become the primary method for evaluating women with abnormal cervical cytologies. Special considerations for colposcopy performed during pregnancy are also discussed.
For the most recent version of the guidelines, please visit NCCN.org
Patient Attitudes and Issues in Colon Cancer Screening
Dayna S. Early and Darrell M. Gray II
Colorectal cancer (CRC) is largely preventable using screening, primarily through detecting and removing adenomatous polyps during flexible sigmoidoscopy (FS) and colonoscopy, but also through identifying early-stage cancers with fecal occult
